In addition to HCC, TBK1 may also regulate the resistance of other malignant tumor cells to antitumor drugs (Vu and Aplin, 2014; Zhu et al., 2019; Cheng and Cashman, 2020; Zhou et al., 2020). Here, TBK1 is linked to hepatocellular carcinoma.